Nra-Candesartan Hctz 12.5 mg

NRA-Candesartan HCTZ 12.5 MG tablets combine candesartan and hydrochlorothiazide for blood pressure management. This oral medication is designed to support cardiovascular health by combining two active ingredients.

NRA-Candesartan HCTZ 12.5 MG tablets are commonly used to manage high blood pressure. The combination of candesartan, an angiotensin II receptor blocker, and hydrochlorothiazide, a diuretic, works to lower blood pressure by relaxing blood vessels and reducing fluid retention. This medication is often prescribed for individuals who require dual-action therapy to achieve optimal blood pressure control.

Common effects of NRA-Candesartan HCTZ 12.5 MG tablets may include dizziness, fatigue, and mild dehydration due to the diuretic component. Some users might experience a dry cough or mild gastrointestinal discomfort. These effects are generally temporary and may subside as the body adjusts to the medication.

It is important to follow the prescribed dosage and administration instructions for NRA-Candesartan HCTZ 12.5 MG tablets. Patients should stay hydrated and monitor their electrolyte levels, especially potassium and sodium, due to the diuretic effect. Individuals with kidney or liver conditions should consult their healthcare provider before use.

NRA-Candesartan HCTZ 12.5 MG tablets may interact with other medications, including nonsteroidal anti-inflammatory drugs (NSAIDs), lithium, and certain diabetes medications. Alcohol consumption should be limited, as it can enhance the blood pressure-lowering effects and increase the risk of dizziness. Always inform your healthcare provider about all medications you are taking.